FNArena Windows
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
| ASX CODE | LAST PRICE | % MOVE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET | UPSIDE/DOWNSIDE |
|---|---|---|---|---|---|---|---|
| ACL | $2.44 |
|
$3.80 | $2.38 | 13.3 |
$2.85 |
|
| AHX | $0.87 | 0.00% | $0.88 | $0.35 |
|
||
| ALC | $0.11 |
|
$0.14 | $0.06 | 28.2 |
$0.17 |
|
| BMT | $0.16 | 0.00% | $0.33 | $0.14 |
$0.60 |
|
|
| DOC | $0.16 | 0.00% | $0.21 | $0.07 | 19.6 |
$0.17 |
|
| EBO | $21.09 |
|
$38.23 | $20.80 | 15.9 |
$31.273 |
|
| HLS | $0.80 |
|
$1.64 | $0.66 | 25.4 |
$0.867 |
|
| IDX | $2.47 |
|
$3.10 | $1.91 | 19.0 |
$3.567 |
|
| M7T | $0.38 |
|
$0.69 | $0.28 |
$0.76 |
|
|
| MPL | $4.48 |
|
$5.31 | $3.92 | 19.2 |
$5.23 |
|
| MVF | $0.71 |
|
$1.23 | $0.54 | 14.3 |
$0.873 |
|
| NHF | $6.38 |
|
$8.26 | $5.82 | 15.0 |
$7.52 |
|
| RHC | $37.54 |
|
$39.84 | $30.39 | 28.1 |
$36.098 |
|
| SHL | $21.62 |
|
$29.24 | $20.50 | 17.7 |
$25.00 |
|
-2.79% 
16.8% Previous Stories
Healius Offers Digital Carrot, Base Remains Soft
May 25 2022
Recovery in the core business remains important in the near-term for Healius, as benefits from covid testing look likely to soften in the remainder of the year, but longer-term digitisation remains a focus for the company
Ramsay Stakes Future on Mental Health
Dec 20 2021
Its latest acquisition has increased Ramsay Health Care’s exposure to the high growth mental health care segment, but potential opportunity has largely failed to impress analysts
Ramsay Health Care: Finally A Break-Out
Nov 09 2021
Michael Gable of Fairmont Equities notes Ramsay Health Care had been range-bound for a year thus a break-out is significant
Funding Overhang Weighs On Ramsay’s Rebound
Jun 10 2021
With earnings momentum coming out of covid, Ramsay Health Care looks set to rebound from the pandemic downturn in surgeries, but the Spire acquisition raises questions over its balance sheet and funding options
Treasure Chest: More Pfizer Growth For Ebos Group
May 24 2021
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Pfizer will now distribute its PBS medicines via a wholesale model and Ebos Group is one wholesaler/distributor that will benefit
Treasure Chest: Demand Pumps Ramsay Health
Mar 03 2021
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Long-term fundamentals are intact for Ramsay Health Care but views differ on the short-term trajectory as the pandemic still dominates
Healius Enjoying Testing Times
Dec 11 2020
Having divested of its medical centres, Healius has initiated a buyback, revised its dividend policy and outlined new profitability targets
The First Connection
Dec 10 2020
Tim Boreham discusses the future prospects of the health booking platform – 1st Group – with some new opportunities on the horizon
Subdued Recovery For Ramsay Health Care
Nov 16 2020
Ramsay Health Care does not expect a substantial increase in activity going forward, amid a subdued recovery in Australian surgical admissions. Europe is unlikely to contribute to earnings growth in FY21.
Recovery Underway For Sonic Healthcare
Jun 25 2020
The main issue confronting Sonic Healthcare is how quickly routine pathology testing recovers, given temporary government support is underpinning COVID-19 volumes.